Status:
TERMINATED
Treadmill Exercise in Metabolic Syndrome
Lead Sponsor:
Beth Israel Deaconess Medical Center
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The main purpose of this study is to better understand the effects of two types of treadmill exercise programs that include education and/or techniques that may be helpful for exercise among individua...
Eligibility Criteria
Inclusion
- Referred by healthcare provider and given medical clearance for moderate-intensity exercise
- Metabolic syndrome, defined as meeting three or more of the following criteria:
- Obesity or overweight defined as BMI \> 25
- Impaired glycemia (fasting blood sugar of ≥ 100 \[5.6 mmol/L\] or glycated hemoglobin \[A1C\] of ≥ 5.7)
- Increased blood pressure (130/85 mmHg or higher) or if you take medicine for high blood pressure
- Increased fasting levels of triglycerides (≥ 150 or 1.7 mmol/L) or decreased fasting high-density lipoprotein (HDL) cholesterol (less than 40 mg/dL or 1 mmol/L for men or 50 mg/dL or 1.3 mmol/L for women) or if you take any medicines for dyslipidemia
- Between the ages of 18-65
- No regular physical activity (≥ 3 or more days per week) for the past 3 months
Exclusion
- Contraindications for treadmill exercise determined by their physician (e.g., cardiopulmonary limitations or diagnoses) or other inability to do treadmill exercise (e.g., musculoskeletal restrictions or severe balance impairment)
- Confirmed diagnosis of coronary artery disease
- Confirmed diagnosis of diabetes
- Currently taking a beta blocker or calcium channel blocker medication
- Uncontrolled and untreated hypertension, defined as a resting blood pressure of 150/90
- Confirmed diagnosis of chronic obstructive pulmonary disease or other severe lung dysfunction that may interfere with exercise (e.g., severe asthma)
- Self-reported psychotic disorder
- Current practice of mindfulness mediation or mindful movement (e.g., yoga or tai chi), defined as regular daily practice or \>2 classes or self-guided sessions per week in the past three months.
- Non-English speaking
Key Trial Info
Start Date :
January 9 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 20 2021
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03435315
Start Date
January 9 2019
End Date
October 20 2021
Last Update
May 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BIDMC
Boston, Massachusetts, United States, 02215